Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P S Wright

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Cell|October 19, 1990
The FT210 cell line is a mouse G2 phase mutant with a temperature-sensitive CDC2 gene productJ P Th'ng, P S Wright, J Hamaguchi, et al.
Biochemical Pharmacology|June 15, 1991
Disruption of Plasmodium falciparum-infected erythrocyte cytoadherence to human melanoma cells with inhibitors of glycoprotein processingP S Wright, D E Cross-Doersen, K K Schroeder, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 1, 1995
Measurement of mRNA levels in tumor xenografts with quantitative autoradiography and in situ hybridizationP S Wright, D E Cross-Doersen, P A Chmielewski, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 1, 1996
Depletion of estrogen receptor in human breast tumor cells by a novel substituted indole that does not bind to the hormone binding domainA J Bitonti, J A Dumont, F G Salituro, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|September 1, 1995
Regulation of ornithine decarboxylase mRNA levels in human breast cancer cells: pattern of expression and involvement of core enhancer promoter elementP S Wright, J R Cooper, D E Cross-Doersen, et al.
The Journal of Biological Chemistry|July 31, 2001
Expression of p21Waf1/Cip1 and cyclin D1 is increased in butyrate-resistant HeLa cellsA Derjuga, C Richard, M Crosato, et al.
Journal of Medicinal Chemistry|February 15, 2001
Crystal structure of human cyclin-dependent kinase 2 in complex with the adenine-derived inhibitor H717M K Dreyer, D R Borcherding, J A Dumont, et al.
Experimental and Molecular Pathology|February 1, 1997
Quantitation of vascular endothelial growth factor mRNA levels in human breast tumors and metastatic lymph nodesP S Wright, D E Loudy, D E Cross-Doersen, et al.
Cancer Research|March 15, 1994
Regression of human breast tumor xenografts in response to (E)-2'-deoxy-2'-(fluoromethylene)cytidine, an inhibitor of ribonucleoside diphosphate reductaseA J Bitonti, J A Dumont, T L Bush, et al.
Oncology Research|January 1, 1997
Decreased vascular endothelial growth factor expression associated with tumor regression induced by (E)-2'-deoxy-2'-(fluoromethylene)cytidine (MDL 101,731)R D Woessner, D E Loudy, C D Wallace, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Cell|October 19, 1990
The FT210 cell line is a mouse G2 phase mutant with a temperature-sensitive CDC2 gene productJ P Th'ng, P S Wright, J Hamaguchi, et al.
Biochemical Pharmacology|June 15, 1991
Disruption of Plasmodium falciparum-infected erythrocyte cytoadherence to human melanoma cells with inhibitors of glycoprotein processingP S Wright, D E Cross-Doersen, K K Schroeder, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 1, 1995
Measurement of mRNA levels in tumor xenografts with quantitative autoradiography and in situ hybridizationP S Wright, D E Cross-Doersen, P A Chmielewski, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 1, 1996
Depletion of estrogen receptor in human breast tumor cells by a novel substituted indole that does not bind to the hormone binding domainA J Bitonti, J A Dumont, F G Salituro, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|September 1, 1995
Regulation of ornithine decarboxylase mRNA levels in human breast cancer cells: pattern of expression and involvement of core enhancer promoter elementP S Wright, J R Cooper, D E Cross-Doersen, et al.
The Journal of Biological Chemistry|July 31, 2001
Expression of p21Waf1/Cip1 and cyclin D1 is increased in butyrate-resistant HeLa cellsA Derjuga, C Richard, M Crosato, et al.
Journal of Medicinal Chemistry|February 15, 2001
Crystal structure of human cyclin-dependent kinase 2 in complex with the adenine-derived inhibitor H717M K Dreyer, D R Borcherding, J A Dumont, et al.
Experimental and Molecular Pathology|February 1, 1997
Quantitation of vascular endothelial growth factor mRNA levels in human breast tumors and metastatic lymph nodesP S Wright, D E Loudy, D E Cross-Doersen, et al.
Cancer Research|March 15, 1994
Regression of human breast tumor xenografts in response to (E)-2'-deoxy-2'-(fluoromethylene)cytidine, an inhibitor of ribonucleoside diphosphate reductaseA J Bitonti, J A Dumont, T L Bush, et al.
Oncology Research|January 1, 1997
Decreased vascular endothelial growth factor expression associated with tumor regression induced by (E)-2'-deoxy-2'-(fluoromethylene)cytidine (MDL 101,731)R D Woessner, D E Loudy, C D Wallace, et al.
Pageof 8